Literature DB >> 2864844

Electrophysiology of esmolol.

A M Greenspan, S R Spielman, L N Horowitz, S Senior, J Steck, A Laddu.   

Abstract

The electrophysiologic characteristics of esmolol were studied in 14 patients. Ten men and 4 women, mean age 57 years, were electrophysiologically evaluated at baseline, and also at 4 to 8 minutes after the administration of a maintenance infusion of esmolol. Plasma samples for esmolol blood levels were drawn at 10 minutes of the maintenance infusion, at the end of the maintenance infusion and 30 minutes after the maintenance infusion was discontinued. Results of this study showed that esmolol has typical beta-blocker electrophysiologic effects. Its major action was on sinus node function; it prolonged this basic sinus cycle length but had no significant effect on intrinsic automaticity as reflected by the corrected sinus node recovery time and sinoatrial conduction. Direct effects on atrioventricular (AV) nodal function were reflected by effects on AV nodal conduction and refractoriness. There was no direct effect on atrial function and, as expected, no effect on His-Purkinje or ventricular function. The intensity of esmolol's electrophysiologic effects on sinus node function, AV nodal conduction and AH interval is comparable to those of other beta blockers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864844     DOI: 10.1016/0002-9149(85)90912-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.

Authors:  Valentina D A Corino; Frida Sandberg; Luca T Mainardi; Pyotr G Platonov; Leif Sörnmo
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-12-26       Impact factor: 1.468

Review 2.  Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P Benfield; E M Sorkin
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

Review 3.  Drug effects on the sinus node. A clinical perspective.

Authors:  N J Linker; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

4.  Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.

Authors:  C Volz-Zang; B Eckrich; P Jahn; B Schneidrowski; B Schulte; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Modification of the haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination.

Authors:  R Korpinen; L Saarnivaara; K Siren; S Sarna
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.